Volume 5.16 | May 3

Immune Regulation News 5.16 May 3, 2013
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News Facebook  Immune Regulation News Twitter
Thymus Teaches Immune Cells to Ignore Vital Gut Bacteria
When immune cells recognize essential gut bacteria as foreign, inflammatory bowel disease such as ulcerative colitis and Crohn’s disease can be the painful, debilitating result. Researchers showed that the regulatory T cells that keep this from happening in most of us come from the tiny immune organ nestled near the heart. [Press release from Georgia Regents University discussing online prepublication in Nature] Press Release | Abstract

New EasySep™ 15-Minute Mouse Cell Isolation Kits - Calculate Time Savings
PUBLICATIONS (Ranked by impact factor of the journal)

The MicroRNA miR-155 Controls CD8+ T Cell Responses by Regulating Interferon Signaling
Scientists found upregulation of expression of the microRNA miR-155 in primary effector and effector memory CD8+ T cells, but low miR-155 expression in naive and central memory cells. Antiviral CD8+ T cell responses and viral clearance were impaired in miR-155-deficient mice, and this defect was intrinsic to CD8+ T cells, as miR-155-deficient CD8+ T cells mounted greatly diminished primary and memory responses. [Nat Immunol] Abstract

Mast Cell Maturation Is Driven via a Group III Phospholipase A2-Prostaglandin D2-DP1 Receptor Paracrine Axis
PLA2G3 secreted from mast cells were coupled with fibroblastic lipocalin-type PGD2 synthase (L-PGDS) to provide PGD2, which facilitates mast-cell maturation via PGD2 receptor DP1. Mice lacking PLA2G3, L-PGDS or DP1, mast cell-deficient mice reconstituted with PLA2G3-null or DP1-null mast cells, or mast cells cultured with L-PGDS-ablated fibroblasts exhibited impaired maturation and anaphylaxis of mast cells. [Nat Immunol] Abstract

Coexpression of CD49b and LAG-3 Identifies Human and Mouse T Regulatory Type 1 Cells
By gene expression profiling of human CD4+ type 1 T regulatory (Tr1) cell clones, the authors identified the surface markers CD49b and lymphocyte activation gene 3 (LAG-3) as being stably and selectively coexpressed on mouse and human Tr1 cells. [Nat Med] Abstract | Press Release

A Combination of Fluorescent NFAT and H2B Sensors Uncovers Dynamics of T Cell Activation in Real Time during Central Nervous System Autoimmunity
Investigators combined fluorescently labeled nuclear factor of activated T cells (NFAT) with histone protein H2B to create a broadly applicable molecular sensor for intravital imaging of T cell activation. [Nat Med] Abstract

CD40 Ligation Reverses T Cell Tolerance in Acute Myeloid Leukemia
A murine acute myeloid leukemia (AML) model was used to investigate antigen-specific T cell responses against AML cells inoculated i.v. versus s.c. Robust antigen-specific T cell responses were generated against AML cells after s.c., but not i.v., inoculation. [J Clin Invest] Full Article

Metallothioneins Negatively Regulate IL-27-Induced Type 1 Regulatory T-Cell Differentiation
Scientists showed that IL-27 induces metallothioneins (MTs) that in turn prevent type 1 regulatory T (Tr1) cell development. MT expression leads to the reduction of STAT1 and STAT3 phosphorylation under Tr1 differentiation condition, resulting in impaired IL-10 production. [Proc Natl Acad Sci USA] Abstract

The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of At Least Two Viral Domains
Researchers investigated the contribution of Ebola virus proteins in modulating dendritic cell maturation by generating recombinant viruses expressing enhanced green fluorescent protein and carrying mutations affecting several potentially immunomodulating domains. [J Virol] Abstract | Press Release

Attenuated Natural Killer (NK) Cell Activation through NKp80 Is Due to an Anomalous Hemi-Immunoreceptor-Tyrosine-Based Activation Motif (hemITAM) with Impaired Syk Kinase Recruitment Capacity
The authors molecularly dissected the NKp80 hemITAM and demonstrated that two non-consenus amino acids, in particular arginine 6, critically impair both hemITAM phosphorylation and Syk recruitment. Impaired Syk recruitment results in a substantial attenuation of cytotoxic responses upon NKp80 ligation. [J Biol Chem] Abstract | Full Article

Proteinase-Activated Receptor-2 Modulates Human Macrophage Differentiation and Effector Function
Proteinase-activated receptor-2 (PAR-2) expression and activation was investigated on granulocyte macrophage and macrophage macrophages. In both macrophages, the PAR-2-activating peptide, SLIGKV, increased PAR-2 expression and regulated TNF-a and IL-10 secretion in a manner similar to LPS. [Innate Immun] Abstract

IL-6 Activated Integrated BATF/IRF4 Functions in Lymphocytes Are T-bet-Independent and Reversed by Subcutaneous Immunotherapy
Scientists found an inverse correlation between T-bet and Il-6 mRNA expression in asthmatic children. Moreover, experimental subcutaneous immunotherapy in T-bet(-/-)mice inhibited IL-6, IL-21R and lung TH17 cells in a setting of asthma. [Sci Rep] Full Article

Don’t forget to subscribe to our sister publications: Human Immunology News and Immunology of Infectious Disease News!

Hassle-Free PBMC Isolation in Just 15 Minutes


Beyond Oxidative Stress: An Immunologist’s Guide to Reactive Oxygen Species
Reactive oxygen species (ROS) react preferentially with certain atoms to modulate functions ranging from cell homeostasis to cell death. Cellular actions include promotion or suppression of inflammation, immunity and carcinogenesis. ROS chemistry and their pleiotropy make them difficult to localize, to quantify and to manipulate – challenges scientists must overcome to translate ROS biology into medical advances. [Nat Rev Immunol] Abstract

The Th17 Pathway as a Therapeutic Target in Rheumatoid Arthritis and Other Autoimmune and Inflammatory Disorders
The authors provide a clear overview of current knowledge on Th17 cell regulation and the main Th17 effector cytokines in relation to interleukin (IL)-17-mediated conditions, as well as on recent IL-17-related drug developments. [BioDrugs] Abstract

Visit our reviews page to see a complete list of reviews in the immune regulation field.


Lupus Research Institute Tops $170 Million for Novel Research in Lupus
The Lupus Research Institute (LRI) announced a new $170 million milestone – delivering unprecedented novel research funding and unprecedented research results – changing the lives of lupus patients. A new analysis of completed LRI Novel Research grants demonstrates an 84 percent success rate as scientists prove cutting-edge hypotheses, publish results and win extended federal funding to advance original discoveries to clinical development. [Lupus Research Institute] Press Release

King of Sweden Presents Crafoord Award to Feinstein Institute Arthritis Researcher

Peter K. Gregersen, MD, a scientist at The Feinstein Institute for Medical Research was awarded the prestigious Crafoord Prize for his genetic research in the area of rheumatoid arthritis. [Feinstein Institute for Medical Research] Press Release

ImmusanT’s Epitope-Specific Immunotherapy for Celiac Disease Informs the Potential of Vaccines against Other Autoimmune Diseases

ImmusanT and its research partners are utilizing their expertise in celiac disease as a model to increase understanding of antigen-specific immunotherapy for autoimmune diseases. [ImmusanT, Inc.] Press Release

From our sponsor:
View immunology lectures, protocols and other resources on the Human Immunology Portal.


National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)


NEW Gene & Cell Therapy (ASGCT) 16th Annual Meeting
May 15-18, 2013
Salt Lake City, United States

NEW 10th International Summer School on Immunogenetics
September 15-18, 2013
Stintino, Italy

Visit our events page to see a complete list of events in the immune regulation community.


NEW PhD Studentship – The Role of Adipocyte Progenitor Cells during Immune Responses (University of Birmingham)

NEW Postdoctoral Fellowship – Tumor Immunology (Northwestern University – Robert H Lurie Comprehensive Cancer Center)

PhD Studentship – Treating Metastatic Disease by Manipulation of Regulatory T Cells (Cardiff School of Medicine)

Postdoctoral Fellow – Immunological Pathways in Human Inflammatory Bowel Disease (Yale University – School of Medicine)

PhD Studentship – Mucosal immunology (KU Leuven Translational Research Center for Gastrointestinal Disorders)

Postdoctoral Position – Immunology (INSERM 1020)

Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Immune Regulation News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Immune Regulation News: Archives | Events | Contact Us